The International AIDS Conference brings together science, leadership, and community to advance treatment and prevention of HIV. DNDi co-hosted a satellite session on paediatric HIV.
Date: 21 July 2016
The Drugs for Neglected Diseases initiative (DNDi), the Clinton Health Access Initiative (CHAI), UNITAID, and the National Empowerment Network of People living with HIV/AIDS in Kenya (NEPHAK) will be sharing practical and programmatic experience – including both successes and challenges – developing and introducing new paediatric ARV formulations.
This Satellite Session will explore how to ensure that when optimal formulations are developed, they are rapidly adopted and introduced so that large-scale treatment of infants and young children with HIV can be implemented and sustained. The Satellite will bring in perspectives from WHO and affected communities as well as from country implementers, product developers, donor agencies, and non-governmental organizations.
Welcome and Introduction
Polly Clayden, HIV i-Base, Chair & Moderator
Anban Pillay, Executive Director, Department of Health South Africa
Panel 1: What does it take to select, prioritise, and develop optimal ARV formulations for children
Panel 2: How to ensure access to new paediatric formulations within country programmes
Panel 3: What does it take to introduce new formulations and implement programmes?
More information: AIDS 2016 conference